ALKERMES | ALKS - Trade Debtors



ALKERMES reported $370.18M in Trade Debtors for its fiscal quarter ending in September of 2024.

Trade Debtors Change Date
AbbVie USD 11.72B 225M Jun/2024
Acadia Pharmaceuticals USD 110.36M 30K Sep/2024
ALKERMES USD 370.18M 273K Sep/2024
Amgen USD 7.32B 383M Sep/2024
Biogen USD 1.99B 90.1M Sep/2024
BioMarin Pharmaceutical USD 777.55M 86.32M Sep/2024
Bristol-Myers Squibb USD 14.9B 251M Sep/2024
Eli Lilly USD 12.05B 941.5M Sep/2024
Gilead Sciences USD 4.59B 76M Sep/2024
Intra Cellular Therapies USD 145.61M 104K Sep/2024
Ionis Pharmaceuticals USD 18M 9M Sep/2024
J&J USD 16.17B 380M Sep/2024
Malin Corporation EUR 6.5M 6.4M Dec/2023
Merck USD 12.96B 1.6B Jun/2024
Neurocrine Biosciences USD 481.1M 12.9M Sep/2024
Otsuka Holdings JPY 475.5B 59.9B Sep/2024
Pfizer USD 15.09B 135M Jun/2024
Regeneron Pharmaceuticals USD 12.21B 6.5B Sep/2024
Vertex Pharmaceuticals USD 1.75B 94.5M Sep/2024